Blood test could predict Cancer's return after treatment
NCT ID NCT07426250
Summary
This study aims to learn if a blood test that looks for tiny pieces of cancer DNA can help doctors predict outcomes for patients with a limited number of cancer spread sites. It will follow 500 patients receiving targeted local treatments to see if changes in this 'liquid biopsy' test can warn of recurrence earlier than scans. The goal is to gather knowledge to improve future monitoring and treatment decisions, not to test a new therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOMETASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Oncology, Aarhus University Hospital
Aarhus N, 8200, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.